Touchlight Genetics Ltd, founded in 2008, is a British biotechnology company operating in the field of DNA therapies and DNA technology.
Our platform proTL™ process is capable of large-scale enzymatic manufacture of doggybone™ closed linear DNA (dbDNA™). The DNA produced is distinctive in its structure and manufactured without the requirement for bacterial fermentation. dbDNA™ is completely minimal and contains no extraneous sequences traditionally required for plasmid DNA production such as antibiotic resistance genes or bacterial origin of replication.
We have demonstrated the versatility of dbDNA™ in the protection from, and treatment of, infectious disease and cancer in pre clinical models. The scope for the use of these stable, minimal constructs is broad including the areas of gene therapy, veterinary vaccines, stem cell reprogramming and allergy treatment.
Currently located in Leatherhead, Surrey, the company will be moving to state of the art, custom-built laboratories in Hampton, west London in summer 2015. See www.morelands-riverdale.com for details of the new premises.
We are looking to expand our research and development capabilities. The roles will focus on the development of Touchlight’s proprietary DNA technology and exploring its full potential in both therapeutic and non-therapeutic fields. This is an exciting opportunity to join a young dynamic biotech company working at the forefront of DNA research and development.